Cardinal Health, Inc. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $379.00M, a 37800.00% increase year-over-year.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $378.00M, a 0.00% change year-over-year.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-06-30 was $0.00.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for the quarter ending 2025-03-31 was $378.00M.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for fiscal 2026 was $1.36B, a 80.18% increase from fiscal 2025.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for fiscal 2025 was $757.00M, a 0.26% decline from fiscal 2024.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for fiscal 2024 was $759.00M, a 62.18% decline from fiscal 2023.
- Cardinal Health, Inc. treasury stock, value, acquired, cost method for fiscal 2023 was $2.01B, a 100.70% increase from fiscal 2022.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $1.36B 10-K · filed 2026-08-11 | |
| 2025-12-31 | $379.00M 10-Q · filed 2026-02-05 | $1.14B derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-09-30 | $378.00M 10-Q · filed 2025-10-30 | $757.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-11 | $757.00M 10-K · filed 2026-08-11 |
| 2025-03-31 | $378.00M 10-Q · filed 2025-05-01 | $757.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2024-12-31 | $1.00M 10-Q · filed 2026-02-05 | $379.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2024-09-30 | $378.00M 10-Q · filed 2025-10-30 | $632.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-11 | $759.00M 10-K · filed 2026-08-11 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-01 | $1.26B derived: sum of 4 quarters · filed 2025-08-12 |
| 2023-12-31 | $254.00M 10-Q · filed 2025-01-30 | $1.52B derived: sum of 4 quarters · filed 2025-08-12 |
| 2023-09-30 | $505.00M 10-Q · filed 2024-11-01 | $1.51B derived: sum of 4 quarters · filed 2025-08-12 |
| 2023-06-30 | $504.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-12 | $2.01B 10-K · filed 2025-08-12 |
| 2023-03-31 | $253.00M 10-Q · filed 2024-05-02 | $1.50B derived: sum of 4 quarters · filed 2024-08-14 |
| 2022-12-31 | $250.00M 10-Q · filed 2024-02-01 | $1.45B derived: sum of 4 quarters · filed 2024-08-14 |
| 2022-09-30 | $1.00B 10-Q · filed 2023-11-03 | $1.50B derived: sum of 4 quarters · filed 2024-08-14 |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-14 | $1.00B 10-K · filed 2024-08-14 |
| 2022-03-31 | $200.00M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $300.00M 10-Q · filed 2023-02-02 | |
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $200.00M 10-K · filed 2023-08-15 |
| 2021-03-31 | $200.00M 10-Q · filed 2022-05-05 | |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-11 | $350.00M 10-K · filed 2022-08-11 |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-05 | |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-16 | $600.00M 10-K · filed 2021-08-16 |
| 2018-06-30 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $550.00M 10-K · filed 2020-08-13 |
| 2018-03-31 | $300.00M 10-Q · filed 2019-05-09 | |
| 2017-06-30 | $600.00M 10-K · filed 2019-08-20 | |
| 2016-06-30 | $651.00M 10-K · filed 2018-08-22 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-02 | |
| 2015-06-30 | $1.04B 10-K · filed 2017-08-10 | |
| 2014-06-30 | $673.00M 10-K · filed 2016-08-12 | |
| 2013-06-30 | $450.00M 10-K · filed 2015-08-13 | |
| 2012-06-30 | $450.00M 10-K · filed 2014-08-13 | |
| 2011-09-30 | $300.00M 10-Q · filed 2012-05-08 | |
| 2011-06-30 | $250.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-20 | $250.00M 10-K · filed 2013-08-20 |
| 2010-12-31 | $0.00 10-Q · filed 2011-02-08 | |
| 2010-09-30 | $250.00M 8-K/A · filed 2011-11-04 | |
| 2010-06-30 | $250.00M 10-K · filed 2012-08-22 | |
| 2008-06-30 | -$1.09B 10-K/A · filed 2010-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |